Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2018 08:00 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results

-- EXPAREL® net product sales of $82.2 million up 23% over prior year third quarter ---- Full-year EXPAREL net product sales guidance increased to $325 to $330 million ---- Conference Call Today at...
October 30, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Aetna Offers Expanded Coverage for EXPAREL® in Select Ambulatory Surgical Centers

Aetna will reimburse for the use of EXPAREL in ambulatory surgical centers in Florida and New Jersey as part of a pilot program PARSIPPANY, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aetna has...
October 25, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira to Report Third Quarter 2018 Financial Results on Thursday November 1, 2018

PARSIPPANY, N.J., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S....
October 11, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

New Research Reveals Potency and Quantity of Opioids Prescribed for Postsurgical Pain Poses Danger to Patients, their Families and Friends

Patients prescribed nearly 100 to 200 opioid pills to help manage pain from four common procedures Persistent opioid use spikes among millennial women; Nearly one-in-five millennials report becoming...
August 08, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals to Present at the 2018 Wedbush Pacgrow Healthcare Conference

PARSIPPANY, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today reported that it will present at the 2018 Wedbush Pacgrow Healthcare Conference at 9:45 AM ET on...
August 02, 2018 08:00 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results

-- EXPAREL® net product sales of $80.4 million up 15% over prior year second quarter ---- Full-year EXPAREL net product sales guidance increased to $320 to $325 million ---- Conference Call Today at...
July 25, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira to Report Second Quarter 2018 Financial Results on Thursday August 2, 2018

PARSIPPANY, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S....
July 10, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira Reports Preliminary Net EXPAREL® Sales of $80.4 Million for Second Quarter of 2018

PARSIPPANY, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today reported preliminary EXPAREL® (bupivacaine liposome injectable suspension) net product sales of...
June 19, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China

PARSIPPANY, N.J. and SHANGHAI, China, June 19, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) and Nuance Biotech Co. Ltd (Nuance) today announced that they have entered into an...
June 15, 2018 07:30 ET | Source: Pacira Pharmaceuticals, Inc.

Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL®

PARSIPPANY, N.J., June 15, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. today announced further collaboration with Aetna, one of the nation’s leading diversified health care benefits...